Back to Journals » Drug Design, Development and Therapy

Drug Design, Development and Therapy

COPE logo
ISSN: 1177-8881

Journal Articles:

- 5,658 records -

Population Pharmacokinetics and Dose Optimization of Vancomycin in Adult Cancer Patients

Gao J, Gao X, Xu Y, Feng Z, Wang P, Gong W, Wang M

Drug Design, Development and Therapy 2026, 20:608206

Published Date: 20 June 2026

Artificial Intelligence in Selected Domains of Drug Discovery: A Critical Narrative Review

Bin Abdulqader MI, Alsaqabi AA, Mohammed AE, Alghamdi SS

Drug Design, Development and Therapy 2026, 20:607228

Published Date: 19 June 2026

In-vivo Antioxidant Effects of Emodin on Ischemia-Reperfusion Injury of Rat’s Skeletal Muscle

Yiğit D, Oktar GL, Demirtaş H, Özer A, Küçük A, Yığman Z, Tekin E, Arslan M

Drug Design, Development and Therapy 2026, 20:618630

Published Date: 19 June 2026

Optimizing Flumatinib Therapy in Chinese Chronic-Phase Chronic Myeloid Leukemia Based on Therapeutic Drug Monitoring

Cheng F, Wang F, Cui Z, Li Q, Liu X, Li W

Drug Design, Development and Therapy 2026, 20:612207

Published Date: 18 June 2026

The Pan-Inhibitor of Aurora Kinases Danusertib Induces Apoptosis and Autophagy and Suppresses Epithelial-to-Mesenchymal Transition in Human Breast Cancer Cells [Retraction]

Li J, Yang Y, Liu Q, Zhou Z, Pan S, He Z, Zhang X, Yang T, Pan S, Duan W, He S, Chen X, Qiu J, Zhou S

Drug Design, Development and Therapy 2026, 20:633634

Published Date: 18 June 2026

Plumbagin Induces Cell Cycle Arrest and Autophagy and Suppresses Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR-Mediated Pathway in Human Pancreatic Cancer Cells [Retraction]

Wang F, Wang Q, Zhou Z, Yu S, Pan S, He Z, Zhang X, Wang D, Yang Y, Yang T, Sun T, Li M, Qiu J, Zhou S

Drug Design, Development and Therapy 2026, 20:633642

Published Date: 18 June 2026

Nanocarrier-Mediated Delivery Systems of Phytochemicals to Enhance and Accelerate Diabetic Wound Healing Processes

Wahyuningsih ES, Muhaimin M, Chaerunisaa AY, Khairinisa MA

Drug Design, Development and Therapy 2026, 20:607020

Published Date: 18 June 2026

Neurohormonal-Immune Dysregulation in Rosacea: Emerging Perspectives from the Skin-Gut-Brain Axis

Shi L, Li S, Yao X, Zhang Z, Dong Q, Zhang H, Wang X, Bai J, Han H, Fu X, Zheng K, Liang L

Drug Design, Development and Therapy 2026, 20:608151

Published Date: 16 June 2026

Optimizing Colistin Sulfate Dosing in Severe Infections: A Population Pharmacokinetic Model-Guided Approach

Ma Y, Wang Y, Wu X, Wang J, Pang Y, Jia Y, Yang X, Gu J

Drug Design, Development and Therapy 2026, 20:600942

Published Date: 15 June 2026

Effect of End-Stage Kidney Disease Factor on the Sedative Effects of Ciprofol

Sun D, Han M, Huang X, Lu D, Zhu B, Zhou D, Hua M, Kang F, Li J

Drug Design, Development and Therapy 2026, 20:601965

Published Date: 10 June 2026

Age-Stratified ED95 of Remimazolam Tosilate for Moderate Sedation in Pediatric Patients: A Biased Coin Design Study

Zhu B, Meng W, Pan K, Peng L, Chen X, Wang S, Yang C

Drug Design, Development and Therapy 2026, 20:613464

Published Date: 8 June 2026

Oliceridine in the Prevention of Catheter-Related Bladder Discomfort: A Single-Center, Randomized, Double-Blind, Prospective Trial

Jiang RJ, Gao S, Yang Z, Bin XY, Cheng L, Liu SX

Drug Design, Development and Therapy 2026, 20:605184

Published Date: 8 June 2026

Obesity Reduces the Median Effective Dose of Remimazolam in Aged 6–18 Pediatric Patients for Procedural Sedation

Liu TT, Chen J, Jin X, Yang ZS, Yu XQ, Xiao F, Huang XD

Drug Design, Development and Therapy 2026, 20:610851

Published Date: 8 June 2026

The Impact of Polymers in Amorphous Solid Dispersion on the Bioavailability of Sulfonylureas and Meglitinides

Aulifa DL, Wibisono TTDW, Ningsih JD, Christy GDAB, Pertiwi DS, Praja HM, Gazzali AM, Amaliah S, Budiman A

Drug Design, Development and Therapy 2026, 20:610513

Published Date: 8 June 2026

Celecoxib-Loaded “Nano-in-Nano” Hierarchical Delivery System: Structure-Driven Synergistic Optimization of Diffusion Efficiency and Mechanical Stability for Osteoarthritis Therapy

Yang C, He H, Li Y, Huang S, Zhang Y, Xiao W, Peng Z, Luo X, Jiang S, Li Y, Cen L, Jia H, Liu Y, Ban J

Drug Design, Development and Therapy 2026, 20:601447

Published Date: 8 June 2026

Progress in the Treatment of Ulcerative Colitis by Targeting NLRP3 Inflammasome

Chen J, Zhang E, Qian X, Shang X, Yu J, Luo J, Hao W

Drug Design, Development and Therapy 2026, 20:611506

Published Date: 4 June 2026

More articles